Clinical Trial Search

Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…

Primary: Number of Participants Who Scheduled or Completed Cervical Cancer Screening — 28; 21 Participants

Primary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote…

Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59

Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05

Primary: Percent of Patients Receiving GI Consult for FOBT+ Results — 39; 47; 64; 51 percent patients receiving GI consult

Primary: Difference in Percentage of Participants Who Completed Any Cervical PLUS Colorectal Cancer Screening Tests — 18; 1 Participants

Primary: Completion of a Fecal Occult Blood Test (FOBT) — 185; 84 participants

Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01

Primary: Number of Participants Who Completed Colorectal Cancer Screening — 11; 16; 18; 19 Participants

Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001

Primary: Intentions to Get Screened for Colon Cancer — 68.64; 65.51; 64.30 units on a 0-100 scale — p=.362

Primary: Number of Participants With CRC Screening Ordered — 162; 114 Participants — p=0.491

Primary: Number (and Proportion) of Participants Who Request a Colorectal Cancer (CRC) Screening Test — 16; 17; 22; 19 Participants

Primary: Colorectal Cancer (CRC) Screening Rate. — 40.1; 40.2; 19.3 percentage of participants

Primary: Percentage of Cancer Screening Tests Completed - Intention to Treat — 10.2; 6.8; 14.7; 11.0 percentage of screening visits completed — p=<0.001

Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants

Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants

Primary: Assess Colorectal Cancer Screening Completion — 305; 130 Participants

Primary: Overall Screening Adherence — 88; 153; 115; 44 Participants — p=<0.001

Primary: Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms — 57; 118; 19; 110 Participants

Primary: Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) — 598; 192 Participants

Primary: Participants Completing CRC Screening Per Electronic Medical Record Documentation — 37; 59; 27 Participants

Primary: Acceptability of Self-Collection Paired With Mobile Mammography — 33 Participants

Primary: Change in Screening Metrics — 42; 8; 37; 13 Participants

Primary: Colorectal Cancer (CRC) Screening Completion — 17; 69 participants — p=0.32

Primary: Number of Participants in Determining Messages — 1051; 1135; 0 Participants

Primary: Colorectal Cancer Screening by Study Arm — 205; 165; 32 Participants — p=0.04

Primary: Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms — 17; 8 Participants

Primary: Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status — 22.0; 26.9; 56.9; 52.8 Percentage (%) of Participants — p=0.2562